Thursday, February 12, 2026 | 10:57 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Tanmay Tiwary

Tanmay Tiwary

Tanmay Tiwary

Tanmay Tiwary specialises in covering equity markets, focusing primarily on sectors like automobile, FMCG, and new-age/internet companies. With almost five years of experience under his belt, Tiwary has previously worked with HT TechCircle (then NewsCorp TechCircle), CNBC TV, and Republic TV. He has also worked with Forbes and Sportskeeda. He holds post-graduate degrees from the University of Leicester and the Indian Institute of Journalism and News Media, Bengaluru.

Tanmay Tiwary specialises in covering equity markets, focusing primarily on sectors like automobile, FMCG, and new-age/internet companies. With almost five years of experience under his belt, Tiwary has previously worked with HT TechCircle (then NewsCorp TechCircle), CNBC TV, and Republic TV. He has also worked with Forbes and Sportskeeda. He holds post-graduate degrees from the University of Leicester and the Indian Institute of Journalism and News Media, Bengaluru.

Email
Twitter
LinkedIn

Page 6 - Tanmay Tiwary

India Inc faces capital allocation deadlock as demand softens, says Nuvama

In its third annual capital allocation study, Nuvama argued that a rare combination of slowing demand cycles and elevated valuations has left corporate India "all dressed up, but with nowhere to go."

India Inc faces capital allocation deadlock as demand softens, says Nuvama
Updated On : 12 Dec 2025 | 8:38 AM IST

Motilal Oswal initiates IKS, Sagility with 'Buy'; Indegene 'Neutral'

The US remains the world's most lucrative outsourcing market, with healthcare spending touching nearly $5 trillion in CY24, accounting for 17-18 per cent of GDP.

Motilal Oswal initiates IKS, Sagility with 'Buy'; Indegene 'Neutral'
Updated On : 11 Dec 2025 | 11:56 AM IST

Sharekhan upgrades Divi's Labs to 'Buy' on strong FY26-28 growth visibility

The brokerage said Divis Laboratories is entering a stronger growth phase, supported by a robust H2FY26 pipeline and visibility for scale-up over the next two years.

Sharekhan upgrades Divi's Labs to 'Buy' on strong FY26-28 growth visibility
Updated On : 11 Dec 2025 | 11:39 AM IST

Muted FY26 to fuel strong FY27 sales, profit rebound for India Inc: CLSA

After two strong years followed by a prolonged stretch of mid-single-digit revenue growth, India Inc. may be on the cusp of a more robust earnings cycle, analysts said.

Muted FY26 to fuel strong FY27 sales, profit rebound for India Inc: CLSA
Updated On : 11 Dec 2025 | 9:54 AM IST

Emirates NBD infusion to lift RBL Bank's growth prospects: Motilal Oswal

RBL Bank's C/I ratio remains elevated at 70.7 per cent due to investments in retail, digital and risk infrastructure, and lower treasury income in Q2FY26.

Emirates NBD infusion to lift RBL Bank's growth prospects: Motilal Oswal
Updated On : 10 Dec 2025 | 9:09 AM IST

Nuvama starts with 'Buy' on Yatharth Hospitals amid strong growth outlook

Despite healthy performance, Yatharth still operates below industry benchmarks in terms of ARPOB and occupancy, offering major upside potential.

Nuvama starts with 'Buy' on Yatharth Hospitals amid strong growth outlook
Updated On : 10 Dec 2025 | 8:54 AM IST

DBS flags 3 top risks to global markets in 2026; US tech correction looms

According to DBS, the first risk is a sharp correction in US equities, particularly in tech stocks linked to the AI investment wave.

DBS flags 3 top risks to global markets in 2026; US tech correction looms
Updated On : 09 Dec 2025 | 10:50 AM IST

Defence, aerospace to drive Bharat Forge; CV outlook unclear: Motilal Oswal

At the core of the bullish narrative is BHFC's swelling defence order book, now at nearly ₹114,000 crore and executable over the next three to four years.

Defence, aerospace to drive Bharat Forge; CV outlook unclear: Motilal Oswal
Updated On : 09 Dec 2025 | 9:30 AM IST

Analysts see up to 54% upside in Coforge; Nomura calls it top midcap IT bet

Nomura, which termed Coforge its "top pick in the mid-cap India IT services sector," said the company is banking on a solution-led sales strategy to maintain its growth trajectory.

Analysts see up to 54% upside in Coforge; Nomura calls it top midcap IT bet
Updated On : 09 Dec 2025 | 8:44 AM IST

Nuvama upgrades Suzlon to 'Buy' as wind outlook improves, capacity ramps up

Suzlon Energy stock: The brokerage has trimmed its target price to ₹60 from ₹66, reflecting a lower valuation multiple due to a temporary slowdown in central tendering activity.

Nuvama upgrades Suzlon to 'Buy' as wind outlook improves, capacity ramps up
Updated On : 09 Dec 2025 | 8:31 AM IST

Nifty India Defence index down 2%; what's dragging defence stocks today?

Market experts attributed the weakness to a combination of valuation concerns, liquidity pressures and profit booking.

Nifty India Defence index down 2%; what's dragging defence stocks today?
Updated On : 03 Dec 2025 | 11:57 AM IST

Diesel relief, LPG boost: Motilal Oswal pegs 31% upside for HPCL stock

Despite the near-term volatility, HPCL's valuations remain reasonable, the brokerage noted. The stock trades at 1.4x one-year forward price-to-book, slightly above its long-term average of 1.2x.

Diesel relief, LPG boost: Motilal Oswal pegs 31% upside for HPCL stock
Updated On : 03 Dec 2025 | 9:12 AM IST

Gold loans, fee income to power Capri Global; JM Financial starts coverage

JM Financial said the non-bank lender's diversified retail-focused franchise, strong asset quality and expanding non-interest income engine position it well for sustained growth.

Gold loans, fee income to power Capri Global; JM Financial starts coverage
Updated On : 03 Dec 2025 | 9:01 AM IST

Aequs IPO opens December 3; should you bid? Check GMP, price band here

Aequs IPO to open on December 3, 2025: Aequs plans to use the IPO proceeds for a mix of debt reduction and business expansion.

Aequs IPO opens December 3; should you bid? Check GMP, price band here
Updated On : 02 Dec 2025 | 3:22 PM IST

Nifty50 to hit 29,300 by end-2026? Nomura lists top 20 stock picks

Nomura expects Indian markets to trade in the range of 20-22x one-year forward earnings, assuming risk premia remain low.

Nifty50 to hit 29,300 by end-2026? Nomura lists top 20 stock picks
Updated On : 02 Dec 2025 | 9:42 AM IST

Nomura sees re-rating potential in Indian Banks; Axis, ICICI, SBI top picks

The brokerage argued that the profitability downcycle, marked by several quarters of net interest margin (NIM) compression and elevated credit costs, is now behind the sector.

Nomura sees re-rating potential in Indian Banks; Axis, ICICI, SBI top picks
Updated On : 02 Dec 2025 | 8:39 AM IST

Nuvama says 'Buy' again on Coromandel Int'l; 3 drivers behind the call

Analysts at Nuvama expect Coromandel to clock ~15 per cent revenue compound annual growth rate (CAGR) over the next five years, with profitability improving as integration benefits materialise.

Nuvama says 'Buy' again on Coromandel Int'l; 3 drivers behind the call
Updated On : 02 Dec 2025 | 7:46 AM IST

Motilal Oswal flags NTPC Coal-to-Gas boost, but cautions on execution

According to MOFSL, the proposed 5-10 mt/annum coal-to-SNG plant marks a strategic pivot that may improve PLFs, boost energy security, and potentially create new revenue streams.

Motilal Oswal flags NTPC Coal-to-Gas boost, but cautions on execution
Updated On : 01 Dec 2025 | 1:29 PM IST

GAIL outlook brightens as tariff hike, volume revival boost FY27 prospects

PNGRB, in its 27 November order, raised GAIL's integrated pipeline tariff by roughly 12 per cent to ₹65.7 per mmbtu, effective 1 January 2026.

GAIL outlook brightens as tariff hike, volume revival boost FY27 prospects
Updated On : 01 Dec 2025 | 1:28 PM IST

Indian consumer firms to see Q3 margin spur as input costs soften: Nomura

Nomura sees GCPL, Tata Consumer, Marico, and Britannia as the key near-term winners of the commodity downcycle.

Indian consumer firms to see Q3 margin spur as input costs soften: Nomura
Updated On : 01 Dec 2025 | 1:27 PM IST